| Product Code: ETC6186012 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Although Australia is not endemic to many neglected tropical diseases (NTDs), the market for diagnostics, vaccines, and treatments still exists due to international aid programs, research initiatives, and immigrant populations from affected regions. Australian biotech firms and academic institutions are involved in collaborative global efforts to tackle NTDs, influencing local market activities.
Although Australia is not endemic to most neglected tropical diseases (NTDs), the market for diagnostic and therapeutic interventions is driven by immigration and travel-related infections. Research collaborations and government funding for global disease control are indirectly supporting the local industry in developing treatments and vaccines.
The neglected tropical disease (NTD) market in Australia is limited by low disease prevalence domestically, resulting in reduced attention from healthcare policymakers. Funding and interest for diagnostics and treatments are predominantly focused on international aid and global health rather than domestic market expansion.
Although Australia has a relatively low burden of neglected tropical diseases (NTDs), the country`s research expertise and regional proximity to high-burden areas like Southeast Asia make it a hub for NTD research and innovation. Investors can support R&D collaborations, vaccine development, and regional outreach programs to supply medicines and diagnostics across Asia-Pacific.
The Australian government, through the Department of Foreign Affairs and Trade (DFAT), supports global health initiatives that target neglected tropical diseases (NTDs), particularly in the Asia-Pacific region. While NTDs are rare in Australia, government funding for research and international aid indirectly sustains domestic interest in diagnostics and pharmaceutical solutions for these diseases.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neglected Tropical Disease Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neglected Tropical Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neglected Tropical Disease Market - Industry Life Cycle |
3.4 Australia Neglected Tropical Disease Market - Porter's Five Forces |
3.5 Australia Neglected Tropical Disease Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 Australia Neglected Tropical Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Australia Neglected Tropical Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for neglected tropical disease control programs in Australia |
4.2.2 Growing awareness and advocacy efforts by healthcare organizations and non-profit groups |
4.2.3 Rising research and development activities focusing on neglected tropical diseases |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas of Australia |
4.3.2 Challenges in diagnosis and treatment of neglected tropical diseases due to lack of awareness among healthcare providers |
4.3.3 Regulatory hurdles and slow approval processes for new treatments and interventions |
5 Australia Neglected Tropical Disease Market Trends |
6 Australia Neglected Tropical Disease Market, By Types |
6.1 Australia Neglected Tropical Disease Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Australia Neglected Tropical Disease Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Australia Neglected Tropical Disease Market Revenues & Volume, By Dengue, 2021- 2031F |
6.1.4 Australia Neglected Tropical Disease Market Revenues & Volume, By Rabies, 2021- 2031F |
6.1.5 Australia Neglected Tropical Disease Market Revenues & Volume, By Trachoma, 2021- 2031F |
6.1.6 Australia Neglected Tropical Disease Market Revenues & Volume, By Buruli Ulcer, 2021- 2031F |
6.1.7 Australia Neglected Tropical Disease Market Revenues & Volume, By Yaws, 2021- 2031F |
6.1.8 Australia Neglected Tropical Disease Market Revenues & Volume, By Leprosy, 2021- 2031F |
6.1.9 Australia Neglected Tropical Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Australia Neglected Tropical Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Neglected Tropical Disease Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Australia Neglected Tropical Disease Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.3 Australia Neglected Tropical Disease Market Revenues & Volume, By Vaccines, 2021- 2031F |
7 Australia Neglected Tropical Disease Market Import-Export Trade Statistics |
7.1 Australia Neglected Tropical Disease Market Export to Major Countries |
7.2 Australia Neglected Tropical Disease Market Imports from Major Countries |
8 Australia Neglected Tropical Disease Market Key Performance Indicators |
8.1 Percentage increase in government funding allocated specifically for neglected tropical disease control programs |
8.2 Number of healthcare facilities offering screening and treatment services for neglected tropical diseases |
8.3 Research and development investments in new therapies and interventions for neglected tropical diseases |
9 Australia Neglected Tropical Disease Market - Opportunity Assessment |
9.1 Australia Neglected Tropical Disease Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 Australia Neglected Tropical Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Australia Neglected Tropical Disease Market - Competitive Landscape |
10.1 Australia Neglected Tropical Disease Market Revenue Share, By Companies, 2024 |
10.2 Australia Neglected Tropical Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here